Loperamide therapy in a patient with diarrhea and resistant hypertension

American Journal of Hypertension

Volumn 13, Issue 4, 2000, Pages 431-432

  Morimoto, Satoshi ^a,b   Sasaki, Susumu ^a   Itoh, Hiroshi ^a   Nakata, Tetsuo ^a   Takeda, Kazuo ^a   Nakagawa, Masao ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Crohn's disease; Loperamide; Resistant hypertension; Short bowel syndrome

Indexed keywords

AZOSEMIDE; DOXAZOSIN; GUANABENZ; IMIDAPRIL; LOPERAMIDE; NIFEDIPINE;

AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CASE REPORT; CROHN DISEASE; DIARRHEA; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; ESSENTIAL HYPERTENSION; HUMAN; INTESTINE RESECTION; MALE; PRIORITY JOURNAL;

AGED; ANTIDIARRHEALS; ANTIHYPERTENSIVE AGENTS; CROHN DISEASE; DIARRHEA; HUMANS; HYPERTENSION; INTESTINAL ABSORPTION; LOPERAMIDE; MALE;

EID: 0034066840     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(99)00231-9     Document Type: Article

References (9)

1. Black HR: Distinguishing resistant hypertension. Cardiology 1988;5:61-70.
2. Frohlich ED: Classification of resistant hypertension. Hypertension 1988;11:II67-II70.
3. Alderman M, Budner N, Cohen H, et al: Prevalence of drug resistant hypertension. Hypertension 1988;11:II71-II75.
4. Gifford RW Jr: An algorithm for the management of resistant hypertension. Hypertension 1988;11:II71-II75.
5. McAlister FA, Lewanczuk RZ, Teo KK: Resistant hypertension: an overview. Can J Cardiol 1996;12:822-828.
6. Raemsch KD, Sommer J: Pharmacokinetics and metabolism of nifedipine. Hypertension 1983;5(suppl II):18-24.
7. Yamada Y, Endo M, Kohno M, et al: Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. Res Lab Drug Metab 1992;42:457-465.
8. Awouters F, Megens A, Verlinden M, et al: Loperamide. Survey of studies on mechanism of its antidiarrheal activity. Dig Dis Sci 1993;38:977-995.
9. Barbezat G: Recent advances. Gastroenterology. Br Med J 1998;316:125-128.